2. Metabolic Enzyme/Protease
  3. Endogenous Metabolite
  4. Lactodifucotetraose

Lactodifucotetraose  (Synonyms: Difucosyllactose ; 2′,3-Difucosyllactose)

Art. -Nr.: HY-N10530 Reinheit: 99.80%
COA
SDS
Handling Instructions Technical Support

Lactodifucotetraose is a difucosylated human milk oligosaccharide. Lactodifucotetraose inhibits platelet function and the release of inflammatory factors. Lactodifucotetraose can be used for the research of *Campylobacter jejuni*-associated diarrhea and platelet-induced inflammatory processes.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

Lactodifucotetraose

Lactodifucotetraose Chemische Struktur

CAS. Nr. : 20768-11-0

Größe Preis Verfügbarkeit Menge
1 mg Auf Lager
5 mg   Angebot einholen  
10 mg   Angebot einholen  

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

This product is a controlled substance and not for sale in your territory.

Kundenbewertung

Based on 1 Customer Validation

Lactodifucotetraose Related Antibodies

Top Publications Citing Use of Products

Alle Endogenous Metabolite Isoform-spezifische Produkte anzeigen:

Alle Isoformen anzeigen
Human Endogenous Metabolite Microbial Metabolite

  • Biologische Aktivität

  • Reinheit & Dokumentation

  • Verweise

  • Kundenbewertung

Beschreibung

Lactodifucotetraose is a difucosylated human milk oligosaccharide. Lactodifucotetraose inhibits platelet function and the release of inflammatory factors. Lactodifucotetraose can be used for the research of *Campylobacter jejuni*-associated diarrhea and platelet-induced inflammatory processes[1].

In Vitro

Lactodifucotetraose (0-10 mg/mL; 15 min pre-incubation; 2 h thrombin activation) dose-dependently inhibits thrombin-induced release of the proinflammatory proteins RANTES and sCD40L from isolated adult platelets[2].
Lactodifucotetraose (0-2 mg/mL; 15 min pre-incubation; 2 h incubation on collagen-coated wells) inhibits the adhesion of isolated adult platelets to collagen-coated surfaces in a dose-dependent manner[2].
Lactodifucotetraose (0-5 mg/mL; 5 min pre-incubation followed by agonist activation) dose-dependently inhibits aggregation and ATP release of isolated adult platelets activated by Collagen (HY-NP003) or ADP (HY-W010918)[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Lactodifucotetraose Related Antibodies
Molekulargewicht

634.58

Formel

C24H42O19
CAS. Nr.
Appearance

Solid

Color

White to off-white

SMILES

O[C@@H]([C@@H]([C@@H]([C@@H](O1)C)O)O)[C@@H]1O[C@H]([C@@H](O)C=O)[C@@H]([C@H](O)CO)O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O[C@H]3[C@H]([C@@H]([C@@H]([C@@H](O3)C)O)O)O
Structure Classification
Initial Source

human milk
Versand

Room temperature in continental US; may vary elsewhere.
Speicherung
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
Reinheit & Dokumentation

Purity: 99.80%

SDS (252 KB)

COA (260 KB) HNMR (270 KB) RP-HPLC (155 KB)

Handling Instructions (2659 KB)
Verweise
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

Lactodifucotetraose Related Classifications

  • Molaritätsrechner

  • Verdünnungsrechner

Die Formel zur Berechnung von Molaritäten

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)

Diese Gleichung wird häufig abgekürzt als: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Lactodifucotetraose20768-11-0Difucosyllactose 2′,3-DifucosyllactoseEndogenous Metaboliteadult human plateletshuman milk oligosaccharideADPRANTESneonatesbreastfed infantsthrombinsCD40LcollagenCampylobacter jejuniInhibitorinhibitorinhibit

Ihre kürzlich angesehenen Produkte:

Online-Anfrage

Your information is safe with us. * Required Fields.

Produktname

  

Requested Quantity *

Name des Antragstellers *

 

Anrede

E-Mail-Addresse *

 

Telefonnummer *

Department

 

Name der Organisation *

City

Bundesland

Country or Region *

      

Bemerkungen

Massenanfrage

Inquiry Information

Produktname:
Lactodifucotetraose
Art. -Nr.:
HY-N10530
Menge:
MCE Japan Authorized Agent:

Kundenbewertung

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Produktname

  

Lot #

Name des Antragstellers *

 

E-Mail-Addresse *

Telefonnummer

 

Department *

Name der Organisation *

 

Country or Region *

Bemerkungen

SAFETY DATA SHEET (SDS)

English - EN (252 KB) Français - FR (252 KB) Deutsch - DE (252 KB) Norwegian - NO (252 KB) Español - ES (252 KB) Swedish - SV (252 KB) Italian - IT (252 KB) Korean - KR (252 KB) Portuguese - PT (252 KB)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.